Health & bio

NIH Clarifies Oral GLP-1 Small-Molecule Mechanism in Reward Circuitry

Orforglipron and similar compounds modulate brain reward pathways to suppress hedonic appetite, offering non-injectable, cost-effective advantages.

Primary sources · 1
NIH
← View the full 2026-05-02 (Sat) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →